Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation - PubMed (original) (raw)
. 2001 Feb 9;276(6):3743-55.
doi: 10.1074/jbc.M006746200. Epub 2000 Nov 1.
D Szczesna, P R Housmans, J Zhao, F de Freitas, A V Gomes, L Culbreath, J McCue, Y Wang, Y Xu, W G Kerrick, J D Potter
Affiliations
- PMID: 11060294
- DOI: 10.1074/jbc.M006746200
Free article
Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation
T Miller et al. J Biol Chem. 2001.
Free article
Abstract
This study characterizes a transgenic animal model for the troponin T (TnT) mutation (I79N) associated with familial hypertrophic cardiomyopathy. To study the functional consequences of this mutation, we examined a wild type and two I79N-transgenic mouse lines of human cardiac TnT driven by a murine alpha-myosin heavy chain promoter. Extensive characterization of the transgenic I79N lines compared with wild type and/or nontransgenic mice demonstrated: 1) normal survival and no cardiac hypertrophy even with chronic exercise; 2) large increases in Ca(2+) sensitivity of ATPase activity and force in skinned fibers; 3) a substantial increase in the rate of force activation and an increase in the rate of force relaxation; 4) lower maximal force/cross-sectional area and ATPase activity; 5) loss of sensitivity to pH-induced shifts in the Ca(2+) dependence of force; and 6) computer simulations that reproduced experimental observations and suggested that the I79N mutation decreases the apparent off rate of Ca(2+) from troponin C and increases cross-bridge detachment rate g. Simulations for intact living fibers predict a higher basal contractility, a faster rate of force development, slower relaxation, and increased resting tension in transgenic I79N myocardium compared with transgenic wild type. These mechanisms may contribute to mortality in humans, especially in stimulated contractile states.
Similar articles
- Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy.
Knollmann BC, Blatt SA, Horton K, de Freitas F, Miller T, Bell M, Housmans PR, Weissman NJ, Morad M, Potter JD. Knollmann BC, et al. J Biol Chem. 2001 Mar 30;276(13):10039-48. doi: 10.1074/jbc.M006745200. Epub 2000 Dec 11. J Biol Chem. 2001. PMID: 11113119 - F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
Hernandez OM, Szczesna-Cordary D, Knollmann BC, Miller T, Bell M, Zhao J, Sirenko SG, Diaz Z, Guzman G, Xu Y, Wang Y, Kerrick WG, Potter JD. Hernandez OM, et al. J Biol Chem. 2005 Nov 4;280(44):37183-94. doi: 10.1074/jbc.M508114200. Epub 2005 Aug 22. J Biol Chem. 2005. PMID: 16115869 - Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.
Sirenko SG, Potter JD, Knollmann BC. Sirenko SG, et al. J Physiol. 2006 Aug 15;575(Pt 1):201-13. doi: 10.1113/jphysiol.2006.107557. Epub 2006 Jun 15. J Physiol. 2006. PMID: 16777946 Free PMC article. - Role of troponin T in disease.
Gomes AV, Barnes JA, Harada K, Potter JD. Gomes AV, et al. Mol Cell Biochem. 2004 Aug;263(1-2):115-29. doi: 10.1023/B:MCBI.0000041853.20588.a0. Mol Cell Biochem. 2004. PMID: 15524172 Review.
Cited by
- TNNT2 mutations in the tropomyosin binding region of TNT1 disrupt its role in contractile inhibition and stimulate cardiac dysfunction.
Madan A, Viswanathan MC, Woulfe KC, Schmidt W, Sidor A, Liu T, Nguyen TH, Trinh B, Wilson C, Madathil S, Vogler G, O'Rourke B, Biesiadecki BJ, Tobacman LS, Cammarato A. Madan A, et al. Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18822-18831. doi: 10.1073/pnas.2001692117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690703 Free PMC article. - Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions.
Duggal D, Nagwekar J, Rich R, Huang W, Midde K, Fudala R, Das H, Gryczynski I, Szczesna-Cordary D, Borejdo J. Duggal D, et al. Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1248-57. doi: 10.1152/ajpheart.00834.2014. Epub 2015 Mar 13. Am J Physiol Heart Circ Physiol. 2015. PMID: 25770245 Free PMC article. - Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations.
Yang Z, Chen J, Li H, Lin Y. Yang Z, et al. Rev Cardiovasc Med. 2022 May 25;23(6):185. doi: 10.31083/j.rcm2306185. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077162 Free PMC article. Review. - Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.
Chen PP, Patel JR, Powers PA, Fitzsimons DP, Moss RL. Chen PP, et al. Circulation. 2012 Sep 4;126(10):1194-205. doi: 10.1161/CIRCULATIONAHA.111.089219. Epub 2012 Jul 24. Circulation. 2012. PMID: 22829020 Free PMC article. - Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L, Kim K, Parikh S, Cadar AG, Bersell KR, He H, Pinto JR, Kryshtal DO, Knollmann BC. Wang L, et al. J Mol Cell Cardiol. 2018 Jan;114:320-327. doi: 10.1016/j.yjmcc.2017.12.002. Epub 2017 Dec 5. J Mol Cell Cardiol. 2018. PMID: 29217433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous